News
AWH
0.1410
+0.71%
0.0010
Why Aspira Women's Health (AWH) Stock Is Skyrocketing
Benzinga · 2d ago
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Benzinga · 2d ago
Weekly Report: what happened at AWH last week (0303-0307)?
Weekly Report · 3d ago
Weekly Report: what happened at AWH last week (0224-0228)?
Weekly Report · 03/03 12:21
Weekly Report: what happened at AWH last week (0217-0221)?
Weekly Report · 02/24 12:21
Weekly Report: what happened at AWH last week (0210-0214)?
Weekly Report · 02/17 12:17
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 02/13 12:05
Aspira Women’s Health appoints Ellen Beausang to board of directors
TipRanks · 02/11 14:35
Aspira Women’s Health Announces Leadership Changes in 2025
TipRanks · 02/10 22:30
Weekly Report: what happened at AWH last week (0203-0207)?
Weekly Report · 02/10 12:08
Weekly Report: what happened at AWH last week (0127-0131)?
Weekly Report · 02/03 12:15
ASPIRA WOMEN'S HEALTH  - FILES FOR OFFERING UP TO 50 UNITS, 50 MLN PRE-FUNDED UNITS
Reuters · 01/31 14:49
Aspira Women’s Health Announces Key Leadership Changes
TipRanks · 01/31 11:48
ASPIRA WOMEN'S HEALTH INC - CO'S INTERIM CEO SANDRA MILLIGAN TO REMAIN AS PRESIDENT
Reuters · 01/31 11:16
ASPIRA WOMEN'S HEALTH INC - ON JAN 28, APPOINTS JAMES CRAWFORD TO SERVE AS PRINCIPAL FINANCIAL OFFICER
Reuters · 01/31 11:16
ASPIRA WOMEN'S HEALTH INC - ON JAN 28, APPOINTS MICHAEL BUHLE AS CEO
Reuters · 01/31 11:16
Weekly Report: what happened at AWH last week (0120-0124)?
Weekly Report · 01/27 12:20
Weekly Report: what happened at AWH last week (0113-0117)?
Weekly Report · 01/20 12:07
Weekly Report: what happened at AWH last week (0106-0110)?
Weekly Report · 01/13 12:08
Aspira Women’s Health appoints Mike Buhle as SVP, commercial operations
TipRanks · 01/10 13:41
More
Webull provides a variety of real-time AWH stock news. You can receive the latest news about Aspira Womens Health Inc through multiple platforms. This information may help you make smarter investment decisions.
About AWH
More
Aspira Women's Health Inc. is engaged in the discovery, development, and commercialization of noninvasive, artificial intelligence (AI)-powered tests to aid in the diagnosis of gynecologic diseases. The Company's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their initial clinical assessment indicates the mass is indeterminate or benign. The Ova1Plus workflow is designed to assess the risk of ovarian malignancy in women planning for surgery and uses two tests, Ova1 as the primary test and Overa as a reflex for Ova1 intermediate range results. Its in-development test pipeline includes OvaMDxSM risk assessment, EndoCheck and EndoMDx, which are designed to expand its ovarian cancer portfolio and address the tremendous need for noninvasive diagnostics for endometriosis. EndoCheck is a noninvasive test designed to identify endometriomas.